All In Biotech

Free tool

FAERS Monitor: Fludeoxyglucose F18

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021870 or its brand name (Fludeoxyglucose F18, Fludeoxyglucose F-18). Reports on generic versions are filed under their own applications.

Reports

274

Serious

204

74% of reports

Hospitalization

111

Death reported

43

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • cytokine release syndrome24
  • drug ineffective17
  • nausea16
  • off label use15
  • hypotension13
  • neutropenia13
  • platelet count decreased12
  • pyrexia12
  • rash maculo-papular11
  • bone marrow failure10
  • death10
  • wrong product administered10
  • covid-199
  • dyspnoea9
  • febrile neutropenia9

Reports by year received

View as table
YearReports
20051
20062
20099
20106
20118
201214
20136
20163
20179
20184
20195
202013
202118
202242
202351
202424
202536
202623

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,885 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wrong product administeredSignal10113.861.91,007
cytokine release syndromeSignal2492.062.72,069
rash maculo-papularSignal1138.021.3360
bone marrow failureSignal1037.820.6323
febrile neutropeniaSignal910.45.568
platelet count decreasedSignal128.65.074
neutropeniaSignal137.34.365
hypotensionSignal135.02.938
covid-19Signal93.92.117
pyrexiaSignal122.71.511
nausea161.61.03
off label use151.30.81
dyspnoea91.20.60
drug ineffective171.00.60
death100.90.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.